Biotech Blahs: Unable To Hold Gains After ASCO Run-Up

As of midday trading Friday biotech stocks are trading down near the May lows erasing gains from the ASCO run-up. Nonetheless, there is plenty of interest in the sector with tons of cash waiting in the wings to move individual stocks.